HHS to invest $650M in rapid COVID testing

By LabPulse.com staff writers

November 12, 2021 -- The U.S. Department of Health and Human Services (HHS) will invest $650 million from the American Rescue Plan to strengthen manufacturing capacity for COVID-19 diagnostic testing through rapid point-of-care molecular tests.

The funds will be used to ramp up U.S. manufacturing capacity for COVID-19 diagnostic tests, thus minimizing reliance on imports from overseas and sustaining long-term manufacturing throughout 2022. The funding will also support purchasing raw materials and finished tests to increase the country's supply of diagnostic tests.

This initiative builds on recent efforts to strengthen diagnostic testing and make tests more available nationwide. President Joe Biden recently announced $3 billion in new investments in rapid testing. The HHS also recently announced a series of actions to help reduce costs, make tests more available, and support bringing more over-the-counter COVID-19 tests to market in the U.S.

Eurofins lands $30M COVID diagnostic testing contract
Eurofins Genomics has won a $30 million contract with the U.S. Department of Air Force and the U.S. Department of Health and Human Services to build...
One year later, lab specialists reflect on life in the shadow of COVID-19
It all started with ominous reports at the end of 2019 about a highly contagious virus that had emerged in Wuhan, China, seemingly a world away. But a...
HHS outsources review of some lab-developed COVID-19 tests
The U.S. Department of Health and Human Services (HHS) has decided to outsource some review of lab-developed tests for COVID-19 to private companies....
Bottlenecks in testing supplies short-circuit U.S. COVID-19 response
Supply shortages have plagued the U.S. response to COVID-19 testing, and the federal government is open to new ideas for solutions, according to a presentation...
HHS: FDA review not needed for coronavirus LDTs
Laboratory-developed tests (LDTs) to diagnose whether patients are infected with the SARS-CoV-2 virus will not have to undergo review by the U.S. Food...

Copyright © 2021 LabPulse.com

Last Updated ls 11/12/2021 10:26:35 AM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current